SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001396814-23-000017
Filing Date
2023-04-03
Accepted
2023-04-03 08:02:52
Documents
16
Period of Report
2023-03-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K pcrx-20230331.htm   iXBRL 8-K 32631
2 EX-10.1 ex101creditagreement.htm EX-10.1 1251194
3 EX-99.1 ex991creditagreement.htm EX-99.1 15247
7 PACIRA BIOSCIENCES LOGO pacirabiosciences.jpg GRAPHIC 27796
8 JPMORGAN LOGO jpmorganlogoa.jpg GRAPHIC 4737
  Complete submission text file 0001396814-23-000017.txt   1689453

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20230331.xsd EX-101.SCH 1909
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20230331_lab.xml EX-101.LAB 24132
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20230331_pre.xml EX-101.PRE 12516
10 EXTRACTED XBRL INSTANCE DOCUMENT pcrx-20230331_htm.xml XML 4282
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609 813-553-6680
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 23790688
SIC: 2834 Pharmaceutical Preparations